About Us...
The ISF primarily addresses the following key issues:

• Early diagnosis and identification of patients at risk
• Best use of current management strategies
• Integration of monoclonal antibodies and other emerging new adjunctive therapies into current treatment strategies
• Ethical and economic issues that influence management decision-making
• Standardization of training provided to intensive care providers

International Sepsis Forum Objectives...

The International Sepsis Forum is designed to

• Harness expert opinion
• Encourage debate and exchange of knowledge
• Evaluate the latest data and theories
• Develop state-of-the-art management guidelines
• Communicate with ICU teams and other critical care teams worldwide through publications, associated educational materials, workshops, international congresses, and this Internet website
• Communicate with Laypersons through publications and associated educational materials and this website

International Sepsis Forum History...
The ISF was launched in March 1997 originally sponsored by Bayer Pharmaceuticals with a goal to define severe sepsis and septic shock and create management guidelines for their treatment; it shortly became a multi-sponsored group supported by unrestricted education grants from Pharmaceutical and Diagnostic companies along with donations from the general public.

ISF and a number of collaborators developed Guidelines for the Management of Severe Sepsis and Septic Shock that were published in Intensive Care Medicine, Volume 27, Supplement 1, 2001. These guidelines were used by the Surviving Sepsis Campaign (SSC) as the starting point for a guideline revision that lead to the bundles and global database and have recently shown a reduction in mortality when the management bundles are used in institutions (by oral communication at SCCM 2009). ISF was a founding partner of the SSC along with SCCM and ESICM.

In 2001 the ISF held its 1st Annual Colloquium at Queens College Cambridge, UK. The annual colloquia were originally closed events by invitation only. In 2008 the colloquia became open to scientists and researchers. These colloquia are keep small (no more than 125 persons) and the program is cutting edge science.

In 2007 to celebrate the 10th anniversary of the ISF Sepsis 2007 was held at the Institut Pasteur in Paris, France; the success of this meeting has led to Sepsis 2008 in Granada Spain, Sepsis 2009 in Amsterdam, The Netherlands and Sepsis 2010 whihc will be held in Paris France 1-3 September. The Sepsis 20XX meeting series programs are of practical nature to researchers and clinicians alike.

ISF had undertaken several consensus meetings and published many publications.

The ISF is a registered charity in England & Wales. 

This page last updated 10/23/2009